Marshall Wace North America’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $11.8M | Buy |
152,108
+118,275
| +350% | +$9.14M | 0.05% | 319 |
|
|
2021
Q2 | $2.82M | Buy |
+33,833
| New | +$2.82M | 0.01% | 701 |
|
|
2021
Q1 | – | Sell |
-404,687
| Closed | -$35.5M | – | 1475 |
|
|
2020
Q4 | $35.5M | Sell |
404,687
-588,168
| -59% | -$51.6M | 0.16% | 157 |
|
|
2020
Q3 | $75.5M | Buy |
992,855
+521,365
| +111% | +$39.7M | 0.48% | 44 |
|
|
2020
Q2 | $58.2M | Sell |
471,490
-256,268
| -35% | -$31.6M | 0.38% | 66 |
|
|
2020
Q1 | $61.5M | Buy |
727,758
+471,483
| +184% | +$39.8M | 0.47% | 60 |
|
|
2019
Q4 | $21.7M | Buy |
256,275
+21,908
| +9% | +$1.85M | 0.1% | 192 |
|
|
2019
Q3 | $15.8M | Sell |
234,367
-305,838
| -57% | -$20.6M | 0.09% | 197 |
|
|
2019
Q2 | $46.3M | Buy |
540,205
+135,130
| +33% | +$11.6M | 0.29% | 93 |
|
|
2019
Q1 | $36M | Sell |
405,075
-314,680
| -44% | -$28M | 0.25% | 98 |
|
|
2018
Q4 | $61.3M | Buy |
719,755
+164,546
| +30% | +$14M | 0.59% | 46 |
|
|
2018
Q3 | $53.8M | Buy |
555,209
+257,073
| +86% | +$24.9M | 0.37% | 73 |
|
|
2018
Q2 | $28.1M | Buy |
+298,136
| New | +$28.1M | 0.16% | 152 |
|
|
2018
Q1 | – | Sell |
-437,830
| Closed | -$39M | – | 1436 |
|
|
2017
Q4 | $39M | Buy |
437,830
+413,173
| +1,676% | +$36.8M | 0.22% | 105 |
|
|
2017
Q3 | $2.29M | Sell |
24,657
-227,908
| -90% | -$21.2M | 0.01% | 762 |
|
|
2017
Q2 | $23M | Sell |
252,565
-172,618
| -41% | -$15.7M | 0.17% | 156 |
|
|
2017
Q1 | $37.4M | Buy |
+425,183
| New | +$37.4M | 0.3% | 98 |
|